FI941117A0 - Bentsyyli-imidatsopyridiinijohdannaiset angiotensiini II reseptoriantagonisteina - Google Patents

Bentsyyli-imidatsopyridiinijohdannaiset angiotensiini II reseptoriantagonisteina

Info

Publication number
FI941117A0
FI941117A0 FI941117A FI941117A FI941117A0 FI 941117 A0 FI941117 A0 FI 941117A0 FI 941117 A FI941117 A FI 941117A FI 941117 A FI941117 A FI 941117A FI 941117 A0 FI941117 A0 FI 941117A0
Authority
FI
Finland
Prior art keywords
benzylimidazopyridine
angiotensin
derivatives
receptor antagonists
antagonists
Prior art date
Application number
FI941117A
Other languages
English (en)
Swedish (sv)
Other versions
FI941117A (fi
Inventor
Silva Jardine Paul A Da
Ronald T Wester
Philip A Carpino
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI941117A0 publication Critical patent/FI941117A0/fi
Publication of FI941117A publication Critical patent/FI941117A/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/06Antiglaucoma agents or miotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6561Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI941117A 1993-03-10 1994-03-09 Bentsyyli-imidatsopyridiinijohdannaiset angiotensiini II reseptoriantagonisteina FI941117A (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4395893A 1993-03-10 1993-03-10

Publications (2)

Publication Number Publication Date
FI941117A0 true FI941117A0 (fi) 1994-03-09
FI941117A FI941117A (fi) 1994-09-11

Family

ID=21929806

Family Applications (1)

Application Number Title Priority Date Filing Date
FI941117A FI941117A (fi) 1993-03-10 1994-03-09 Bentsyyli-imidatsopyridiinijohdannaiset angiotensiini II reseptoriantagonisteina

Country Status (7)

Country Link
EP (1) EP0690859A1 (fi)
JP (1) JPH08502757A (fi)
AU (1) AU6297494A (fi)
CA (1) CA2157037A1 (fi)
FI (1) FI941117A (fi)
IL (1) IL108842A0 (fi)
WO (1) WO1994020499A1 (fi)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4200954A1 (de) * 1991-04-26 1992-10-29 Bayer Ag Heterocyclisch substituierte phenylessigsaeurederivate

Also Published As

Publication number Publication date
FI941117A (fi) 1994-09-11
EP0690859A1 (en) 1996-01-10
CA2157037A1 (en) 1994-09-15
JPH08502757A (ja) 1996-03-26
IL108842A0 (en) 1994-06-24
AU6297494A (en) 1994-09-26
WO1994020499A1 (en) 1994-09-15

Similar Documents

Publication Publication Date Title
NO985225L (no) Indolderivater nyttige som endotelinreseptorantagonister
NO972016D0 (no) Indolyl-Y-reseptorantagonister
DE69734833D1 (de) Vitronektin rezeptor antagonisten
DE69812096D1 (de) Neuropeptid y rezeptorantagonisten
DK0630376T3 (da) Kondenserede indolderivater som 5-HT4-receptorantagonister
NO965036D0 (no) Kinolinderivater som techykinin NK3 reseptor-antagonister
NO981477L (no) Pyrimidinderivater som 5HT2C-reseptor antagonister
DK0569013T3 (da) Quinolinforbindelser som angiotensin II antagonister
ID16742A (id) Antagonis reseptor endotelin
FI961628A (fi) Indolijohdannaisia NMDA-antagonisteina
NO974043D0 (no) Indolderivater som EAA-antagonister
ID24726A (id) Antagonis-antagonis reseptor trombin
KR960700722A (ko) 피브리노겐 수용체 길항제(Fibrinogen receptor antagonists)
ID24162A (id) Antagonis-antagonis reseptor vitronektin
DK0906294T3 (da) Benzoxazinon-dopamin D4-receptor-antagonister
FI951798A0 (fi) Bentsofuraanijohdannaiset 5-HT1-kaltaisina reseptoriantagonisteina
NO985970L (no) Indolinderivater anvendelige som 5_HT-2C-reseptor-antagonister
NO961333D0 (no) Nye pyrazolderivater som angiotensin-II-antagonister
NO972612D0 (no) Pyridazoner som endotelinreseptorantagonister
FI943359A0 (fi) Atsasykliset-heterosykliset yhdisteet angiotensiini II reseptoriantagonisteina
NO985972L (no) Indolinderivater anvendelige som 5-HT-2C reseptorantagonister
NO950684D0 (no) Nye imidazopyridinderivater som angiotensinII-antagonister
NO974205L (no) Heterocyklisk-substituerte piperazinonderivater som tachykininreceptor-antagonister
FI941118A0 (fi) Bentsyyli-imidatsopyridiinijohdannainen angiotensiini II reseptoriantagonistina
ATE208764T1 (de) Isazole derivate als fibrinogen-rezeptor- antagonisten